case_images: PMC3465891_01
case_images: Dorsal view of the necrotic ulcer on the glans penis.
case_images: CRIM.PATHOLOGY2012-948352.001.jpg
case_images: PMC3465891_01_CRIM.PATHOLOGY2012-948352.001.jpg
case_images: fig1
case_images: His physical examination revealed a large well-demarcated penile ulcer with a necrotic base (Figure 1).
case_images: Sonographic imaging of the case. (a) Transabdominal US of the pelvis (sagittal section) shows an enlarged and markedly hypoechoic prostate (asterisk), with indistinct borders. Irregular thickening of the bladder wall is also noted (arrow). (b) Transrectal US confirms infiltration of the prostate by a bulky, lobulated, hypoechoic mass (arrows) which also involves the base of the penis. (c) Transabdominal US (comparable section with (a)) shows resolution of the infiltrative process.
case_images: CRIM.PATHOLOGY2012-948352.002.jpg
case_images: PMC3465891_01_CRIM.PATHOLOGY2012-948352.002.jpg
case_images: fig2
case_images: The prostate was enlarged (volume: 80 mL), hypoechoic and with indistinct borders (Figure 2(a)). Transrectal US examination showed that the shaft of the penis and the right prostate lobe were infiltrated by a solid, ill-defined, hypoechoic mass (Figure 2(b)). In the posttreatment transabdominal US the bladder and prostate lesions also had completely resolved (Figure 2(c)).
case_images: Pathology image.
case_images: CRIM.PATHOLOGY2012-948352.003.jpg
case_images: PMC3465891_01_CRIM.PATHOLOGY2012-948352.003.jpg
case_images: fig3
case_images: The immunophenotyping showed positive staining, diffusely for LCA, CD19, CD20, CD79 and focally for CD3, CD5, CD68, and no staining for epithelial and neuroendocrine markers or melanoma-specific markers (Figures 3, 4, and 5).
case_images: Pathology image (CD19 immunostain).
case_images: CRIM.PATHOLOGY2012-948352.004.jpg
case_images: PMC3465891_01_CRIM.PATHOLOGY2012-948352.004.jpg
case_images: fig4
case_images: The immunophenotyping showed positive staining, diffusely for LCA, CD19, CD20, CD79 and focally for CD3, CD5, CD68, and no staining for epithelial and neuroendocrine markers or melanoma-specific markers (Figures 3, 4, and 5).
case_images: Pathology image (CD30 immunostain).
case_images: CRIM.PATHOLOGY2012-948352.005.jpg
case_images: PMC3465891_01_CRIM.PATHOLOGY2012-948352.005.jpg
case_images: fig5
case_images: The immunophenotyping showed positive staining, diffusely for LCA, CD19, CD20, CD79 and focally for CD3, CD5, CD68, and no staining for epithelial and neuroendocrine markers or melanoma-specific markers (Figures 3, 4, and 5).